| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.058 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |